Pulmuone Overview
- Year Founded
-
1981

- Status
-
Public
- Employees
-
528

- Stock Symbol
-
017810

- Investments
-
14
- Share Price
-
$9.18
- (As of Thursday Closing)
Pulmuone General Information
Description
Pulmuone Corp is a South Korean company involved in food manufacturing and food material distribution. The company's businesses are production of tofu, bean sprouts, eggs, and noodles; chilled delivery logistics; food service, food material distribution; and manufacture of healthcare foods, also includes mineral water, and fermented milk, concession businesses.
Contact Information
Website
www.pulmuone.co.krCorporate Office
- 8th floor Rosedale Building
- 280, Gwangpyeong-ro, Gwangpyeong-ro
- Seoul, 369-821
- South Korea
Corporate Office
- 8th floor Rosedale Building
- 280, Gwangpyeong-ro, Gwangpyeong-ro
- Seoul, 369-821
- South Korea
Pulmuone Stock Performance
As of 12-Jun-2025, Pulmuone’s stock price is $9.18. Its current market cap is $339M with 36.9M shares.
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$9.18 | $9.33 | $6.77 - $13.50 | $339M | 36.9M | 127K | $0.35 |
Pulmuone Financials Summary
As of 31-Mar-2025, Pulmuone has a trailing 12-month revenue of $2.32B.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 1,255,188 | 1,100,921 | 995,709 | 923,958 |
Revenue | 2,321,205 | 2,355,328 | 2,289,548 | 2,196,629 |
EBITDA | 185,886 | 193,379 | 164,473 | 120,482 |
Net Income | 22,399 | 25,947 | 14,927 | (14,397) |
Total Assets | 1,575,137 | 1,582,623 | 1,673,643 | 1,622,616 |
Total Debt | 838,628 | 835,636 | 922,167 | 826,130 |
Pulmuone Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Pulmuone Comparisons
Industry
Financing
Details
Pulmuone Competitors (8)
One of Pulmuone’s 8 competitors is Unlimeat, a Venture Capital-Backed company based in Seoul, South Korea.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Unlimeat | Venture Capital-Backed | Seoul, South Korea | ||||
DevotionFoods | Venture Capital-Backed | Seoul, South Korea | ||||
Hormel Foods | Corporation | Austin, MN | ||||
AAK | Corporation | Malmo, Sweden | ||||
Shinsegae Food Company | Corporation | Seoul, South Korea |
Pulmuone Patents
Pulmuone Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20250109447-A1 | Crispr-cas-based composition for salmonella detection and salmonella detection method using same | Pending | 23-Feb-2022 | ||
US-20180184694-A1 | Preparation method of noodle with enhanced cooking convenience | Inactive | 30-Dec-2016 | ||
US-20140302199-A1 | Tofu manufacturing process | Inactive | 03-Jun-2013 | A23C20/025 |
Pulmuone Signals
Pulmuone Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Pulmuone Investments & Acquisitions (14)
Pulmuone’s most recent deal was a Later Stage VC with MyBenefit (Information Services (B2C)) for . The deal was made on 29-Aug-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
MyBenefit (Information Services (B2C)) | 29-Aug-2024 | Later Stage VC | Information Services (B2C) | ||
Samsoseul | 09-Jul-2024 | Merger/Acquisition | Other Commercial Products | ||
SIMPLE planet. | 12-Feb-2023 | Early Stage VC | Other Commercial Products | ||
Asahico | 01-Jan-2022 | Secondary Transaction - Private | Food Products | ||
Pulmuone Waters | 01-Feb-2021 | Secondary Transaction - Private | Beverages |
Pulmuone ESG
Risk Overview
Risk Rating
Updated May, 25, 2022
23.15 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,912
Rank
Percentile

Food Products
Industry
of 591
Rank
Percentile

Packaged Foods
Subindustry
of 347
Rank
Percentile

Pulmuone Affiliates
Subsidiaries (5)
Name | Industry | Location | Year Founded |
---|---|---|---|
Formida Health Life | Seoul, South Korea | 2024 | |
Nasoya Foods USA | Ayer, MA | 1978 | |
Asahico | Tokyo, Japan | 1972 | |
Asahi Food Processing | Asaka, Japan | ||
JV (Pulmuone Holdings / Shanghai Fusheng Soya-Food / Shanghai Zhangxiaobao Green Food Development) | China |
Pulmuone FAQs
-
When was Pulmuone founded?
Pulmuone was founded in 1981.
-
Where is Pulmuone headquartered?
Pulmuone is headquartered in Seoul, South Korea.
-
What is the size of Pulmuone?
Pulmuone has 528 total employees.
-
What industry is Pulmuone in?
Pulmuone’s primary industry is Food Products.
-
Is Pulmuone a private or public company?
Pulmuone is a Public company.
-
What is Pulmuone’s stock symbol?
The ticker symbol for Pulmuone is 017810.
-
What is the current stock price of Pulmuone?
As of 12-Jun-2025 the stock price of Pulmuone is $9.18.
-
What is the current market cap of Pulmuone?
The current market capitalization of Pulmuone is $339M.
-
What is Pulmuone’s current revenue?
The trailing twelve month revenue for Pulmuone is $2.32B.
-
Who are Pulmuone’s competitors?
Unlimeat, DevotionFoods, Hormel Foods, AAK, and Shinsegae Food Company are some of the 8 competitors of Pulmuone.
-
What is Pulmuone’s annual earnings per share (EPS)?
Pulmuone’s EPS for 12 months was $0.35.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »